Mańkowska-Wierzbicka, D.; Zuraszek, J.; Wierzbicka, A.; Gabryel, M.; Mahadea, D.; Baturo, A.; Zakerska-Banaszak, O.; Slomski, R.; Skrzypczak-Zielinska, M.; Dobrowolska, A.
Alterations in Gut Microbiota Composition in Patients with COVID-19: A Pilot Study of Whole Hypervariable 16S rRNA Gene Sequencing. Biomedicines 2023, 11, 367.
https://doi.org/10.3390/biomedicines11020367
AMA Style
Mańkowska-Wierzbicka D, Zuraszek J, Wierzbicka A, Gabryel M, Mahadea D, Baturo A, Zakerska-Banaszak O, Slomski R, Skrzypczak-Zielinska M, Dobrowolska A.
Alterations in Gut Microbiota Composition in Patients with COVID-19: A Pilot Study of Whole Hypervariable 16S rRNA Gene Sequencing. Biomedicines. 2023; 11(2):367.
https://doi.org/10.3390/biomedicines11020367
Chicago/Turabian Style
Mańkowska-Wierzbicka, Dorota, Joanna Zuraszek, Adrianna Wierzbicka, Marcin Gabryel, Dagmara Mahadea, Alina Baturo, Oliwia Zakerska-Banaszak, Ryszard Slomski, Marzena Skrzypczak-Zielinska, and Agnieszka Dobrowolska.
2023. "Alterations in Gut Microbiota Composition in Patients with COVID-19: A Pilot Study of Whole Hypervariable 16S rRNA Gene Sequencing" Biomedicines 11, no. 2: 367.
https://doi.org/10.3390/biomedicines11020367
APA Style
Mańkowska-Wierzbicka, D., Zuraszek, J., Wierzbicka, A., Gabryel, M., Mahadea, D., Baturo, A., Zakerska-Banaszak, O., Slomski, R., Skrzypczak-Zielinska, M., & Dobrowolska, A.
(2023). Alterations in Gut Microbiota Composition in Patients with COVID-19: A Pilot Study of Whole Hypervariable 16S rRNA Gene Sequencing. Biomedicines, 11(2), 367.
https://doi.org/10.3390/biomedicines11020367
